Pharmacies sue GoodRx and PBMs over ‘illegal’ reimbursement fees

Three unbiased pharmacies have filed separate lawsuits accusing GoodRx, which markets a prescription drug low cost card, of conspiring with a number of pharmacy profit managers to repair reimbursement charges, the most recent skirmish over the opaque pharmaceutical provide chain within the U.S.

At problem are the behind-the-scenes transactions involving generic medicine, which account for an estimated 90% of the prescriptions written within the U.S. and, consequently, signify a profitable market. The lawsuits declare, nevertheless, that GoodRx and a few of the largest PBMs coordinate their reimbursement insurance policies in a manner that has intentionally diminished charges for the pharmacies.

The “anti-competitive” tactic has contributed to deteriorating funds for a rising variety of unbiased pharmacies, in line with the lawsuits, which famous “1000’s” of native drug shops have closed in recent times. The pharmacies argued the dispute is one among a number of over reimbursement charges that, in the end, favor pharmacies affiliated with the PBMs themselves.